Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,275Revenue $M476Net Margin (%)9.4Altman Z-Score3.7
Enterprise Value $M1,313EPS $0.7Operating Margin %14.5Piotroski F-Score7
P/E(ttm)48.9Beneish M-Score-2.4Pre-tax Margin (%)13.4Higher ROA y-yY
Price/Book2.310-y EBITDA Growth Rate %4.4Quick Ratio4.0Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %1.7Current Ratio5.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %26.8ROA % (ttm)4.9Higher Current Ratio y-yY
Dividend Yield %--PEG32.4ROE % (ttm)8.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M38.8ROIC % (ttm)8.6Gross Margin Increase y-yY

Gurus Latest Trades with EBS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EBSKen Fisher 2015-06-30 Reduce$28.76 - $33.69
($30.97)
$ 32.866%Reduce 7.78%462,428
EBSJoel Greenblatt 2014-09-30 Sold Out -0.06%$21.31 - $24.9
($22.93)
$ 32.8643%Sold Out0
EBSJoel Greenblatt 2014-03-31 Buy 0.1%$22.85 - $28.09
($25.19)
$ 32.8630%New holding258,760
EBSJohn Rogers 2014-03-31 Sold Out -0.04%$22.85 - $28.09
($25.19)
$ 32.8630%Sold Out0
EBSJohn Rogers 2013-12-31 Add0.02%$17.71 - $23.95
($20.84)
$ 32.8658%Add 105.79%122,650
EBSJohn Rogers 2013-09-30 Add0.01%$15.22 - $19.43
($17.88)
$ 32.8684%Add 116.73%59,600
EBSJohn Rogers 2013-06-30 Buy 0.01%$13.08 - $15.73
($14.48)
$ 32.86127%New holding27,500
EBSJoel Greenblatt 2013-03-31 Sold Out -0.14%$13.95 - $16.9
($15.67)
$ 32.86110%Sold Out0
EBSJoel Greenblatt 2012-12-31 Buy 0.14%$12.91 - $16.09
($14.64)
$ 32.86124%New holding147,099
EBSKen Fisher 2012-12-31 Add$12.91 - $16.09
($14.64)
$ 32.86124%Add 21.09%401,700
EBSJoel Greenblatt 2011-12-31 Sold Out -0.08%$15.43 - $19.64
($17.41)
$ 32.8689%Sold Out0
EBSJoel Greenblatt 2011-06-30 Reduce-0.05%$20.66 - $24.98
($23.2)
$ 32.8642%Reduce 20.74%26,620
EBSKen Fisher 2011-06-30 Add0.01%$20.66 - $24.98
($23.2)
$ 32.8642%Add 160.57%300,305
EBSJoel Greenblatt 2011-03-31 Add0.17%$20.64 - $24.55
($22.62)
$ 32.8645%Add 243.58%33,585
EBSKen Fisher 2011-03-31 Buy 0.01%$20.64 - $24.55
($22.62)
$ 32.8645%New holding115,250
EBSJoel Greenblatt 2010-12-31 Buy 0.07%$17.59 - $23.8
($19.23)
$ 32.8671%New holding9,775
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EBS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EBS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Richard RonaldDirector 2015-08-13Sell4,922$36-8.72view
JOULWAN GEORGE ADirector 2015-08-13Sell7,200$34.72-5.36view
El-Hibri FuadChairman, 10% Owner 2015-08-10Sell30,000$35.5-7.44view
El-Hibri FuadChairman, 10% Owner 2015-08-06Sell29,766$34.5-4.75view
El-Hibri FuadChairman, 10% Owner 2015-07-20Sell234$34.5-4.75view
Richard RonaldDirector 2015-07-13Sell4,922$34-3.35view
Richard RonaldDirector 2015-06-29Sell4,923$32.760.31view
El-Hibri FuadChairman, 10% Owner 2015-06-22Sell74,564$32.60.8view
SULLIVAN LOUIS WDirector 2015-06-16Sell13,457$31.334.88view
El-Hibri FuadChairman, 10% Owner 2015-06-15Sell45,436$32.182.11view

Quarterly/Annual Reports about EBS:

News about EBS:

Articles On GuruFocus.com
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Nov 05 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Aug 06 2010 
Emergent BioSolutions Inc. (EBS) President & COO Daniel Abdun-nabi sells 18,150 Shares Jul 30 2010 
Weekly CEO Sells Highlight: Yum! Brands Inc, Marchex Inc, iGate Corp, and Emergent BioSolutions Inc. Jul 25 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 18,800 Shares Jul 23 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 130,100 Shares Jul 22 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 84,433 Shares Jul 19 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 52,000 Shares May 14 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) May 06 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 25,000 Shares Apr 29 2010 

More From Other Websites
Emergent BioSolutions, Inc. Earnings Q2, 2015 Sep 01 2015
31.08.2015 - Sergiu Manea to become CEO of BCR, starting with October 1st 2015 Aug 31 2015
26.08.2015 - Erste Bank opens new service branch office at Auhof Center Aug 27 2015
25.08.2015 - Pavel Kysilka decides to leave Česká Spořitelna at the end of 2015. His position... Aug 25 2015
Emergent BioSolutions competitor gets $143M federal contract for anthrax vaccine work Aug 20 2015
Emergent BioSolutions Gets $44M CDC Contract for VIGIV Aug 14 2015
Emergent BioSolutions Receives $44 Million CDC Contract to Further Advance Vaccinia Immune Globulin... Aug 13 2015
Emergent BioSolutions Receives $44 Million CDC Contract to Further Advance Vaccinia Immune Globulin... Aug 13 2015
10-Q for Emergent BioSolutions, Inc. Aug 09 2015
Emergent BioSolutions Tops on Q2 Earnings, Plans Spin-Off - Analyst Blog Aug 07 2015
07.08.2015 - Erste Group posts net profit of EUR 487.2 million in H1 15; Aug 07 2015
07.08.2015 - Erste Group posts net profit of EUR 487.2 million in H1 15; NPL ratio improves to 7.7%,... Aug 07 2015
Edited Transcript of EBS earnings conference call or presentation 6-Aug-15 12:00pm GMT Aug 06 2015
Why spin out a new bio company? When your cancer work isn't getting the attention it deserves. Aug 06 2015
Emergent BioSolutions Proposed Spin-off of BioSciences Business & Q2 2015 Earnings Call scheduled... Aug 06 2015
Emergent BioSolutions Reports Second Quarter and Six Months 2015 Financial Results and Reaffirms... Aug 06 2015
Emergent BioSolutions Announces Plan to Implement Tax-Free Spin-Off of Biosciences Business Into a... Aug 06 2015
Emergent Biosolutions posts 2Q profit Aug 06 2015
Emergent Biosolutions posts 2Q profit Aug 06 2015
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 06 2015
Q2 2015 Emergent BioSolutions Inc Earnings Release - Time Not Supplied Aug 06 2015
Emergent BioSolutions Announces Plan to Implement Tax-Free Spin-Off of Biosciences Business Into a... Aug 06 2015
Emergent BioSolutions Reports Second Quarter and Six Months 2015 Financial Results and Reaffirms... Aug 06 2015
04.08.2015 - pbb and Erste Group provide € 126 million facility to a consortium led by Morgan... Aug 04 2015
Emergent BioSolutions Expands Biodefense Business Through Launch of a Military-Grade Auto-Injector... Aug 03 2015
Emergent BioSolutions Expands Biodefense Business Through Launch of a Military-Grade Auto-Injector... Aug 03 2015
28.07.2015 - Easing cycle in CEE comes to an end - but no hikes in sight Jul 28 2015
27.07.2015 - Erste Group and Global Payments together with CaixaBank form joint venture in CEE to... Jul 27 2015
23.07.2015 - Erste Bank sells its shares in Österreichische Lotterien to Novomatic Jul 23 2015
Emergent BioSolutions to Release Second Quarter 2015 Financial Results and Conduct a Conference Call... Jul 23 2015
Emergent BioSolutions to Release Second Quarter 2015 Financial Results and Conduct a Conference Call... Jul 23 2015
20.07.2015 - Erste Bank and Slovenská sporitelna awarded “Bank of the Year 2015” Jul 20 2015
Emergent BioSolutions Awarded $19.7 Million BARDA Contract to Develop and Manufacture Ebola... Jul 20 2015
Emergent BioSolutions Awarded $19.7 Million BARDA Contract to Develop and Manufacture Ebola... Jul 20 2015
17.07.2015 - Low interest rates are costing every Austrian 2,366 euro Jul 17 2015
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 16 2015
14.07.2015 - Erste Card Club allows 7.5 million Koreans to make payments in Croatia Jul 14 2015
13.07.2015 - Brokerjet service to be discontinued as of 30.11.2015 Jul 13 2015
08.07.2015 - “Career with Children” Jul 08 2015
ProMetic Life Science to Acquire Emergent Biosolutions' Plasma Collection Center in Winnipeg, Canada May 28 2015
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 21 2015
Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00 May 21 2015
EMERGENT BIOSOLUTIONS INC. Financials May 15 2015
Emergent Biosolutions posts 3Q profit Nov 07 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK